• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HPV 型别是否影响口咽癌的预后?

Does HPV type affect outcome in oropharyngeal cancer?

机构信息

Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, Room B3-431A, 800 Commissioners Road East, London, N6A 5W9, , Ontario, Canada.

出版信息

J Otolaryngol Head Neck Surg. 2013 Feb 1;42(1):9. doi: 10.1186/1916-0216-42-9.

DOI:10.1186/1916-0216-42-9
PMID:23663293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3650940/
Abstract

BACKGROUND

An epidemic of human papillomavirus (HPV)-related oropharyngeal squamous cell cancer (OPSCC) has been reported worldwide largely due to oral infection with HPV type-16, which is responsible for approximately 90% of HPV-positive cases. The purpose of this study was to determine the rate of HPV-positive oropharyngeal cancer in Southwestern Ontario, Canada.

METHODS

A retrospective search identified ninety-five patients diagnosed with OPSCC. Pre-treatment biopsy specimens were tested for p16 expression using immunohistochemistry and for HPV-16, HPV-18 and other high-risk subtypes, including 31,33,35,39,45,51,52,56,58,59,67,68, by real-time qPCR.

RESULTS

Fifty-nine tumours (62%) were positive for p16 expression and fifty (53%) were positive for known high-risk HPV types. Of the latter, 45 tumors (90%) were identified as HPV-16 positive, and five tumors (10%) were positive for other high-risk HPV types (HPV-18 (2), HPV-67 (2), HPV-33 (1)). HPV status by qPCR and p16 expression were extremely tightly correlated (p < 0.001, Fishers exact test). Patients with HPV-positive tumors had improved 3-year overall (OS) and disease-free survival (DFS) compared to patients with HPV-negative tumors (90% vs 65%, p = 0.001; and 85% vs 49%, p = 0.005; respectively). HPV-16 related OPSCC presented with cervical metastases more frequently than other high-risk HPV types (p = 0.005) and poorer disease-free survival was observed, although this was not statistically significant.

CONCLUSION

HPV-16 infection is responsible for a significant proportion of OPSCC in Southwestern Ontario. Other high-risk subtypes are responsible for a smaller subset of OPSCC that present less frequently with cervical metastases and may have a different prognosis.

摘要

背景

人乳头瘤病毒(HPV)相关的口咽鳞状细胞癌(OPSCC)在全球范围内呈流行趋势,主要与 HPV 型 16 的口腔感染有关,该型病毒约占 HPV 阳性病例的 90%。本研究旨在确定加拿大安大略省西南部 HPV 阳性口咽癌的发病率。

方法

通过回顾性搜索,确定了 95 例 OPSCC 患者。使用免疫组织化学法检测预处理活检标本中 p16 的表达,并通过实时 qPCR 检测 HPV-16、HPV-18 及其他高危亚型,包括 31、33、35、39、45、51、52、56、58、59、67、68。

结果

59 例肿瘤(62%)p16 表达阳性,50 例(53%)HPV 高危型阳性。后者中,45 例(90%)肿瘤为 HPV-16 阳性,5 例(10%)为其他高危 HPV 型阳性(HPV-18(2),HPV-67(2),HPV-33(1))。qPCR 法和 p16 表达法检测 HPV 状态结果高度相关(p < 0.001,Fisher 确切检验)。HPV 阳性肿瘤患者的 3 年总生存率(OS)和无病生存率(DFS)明显优于 HPV 阴性肿瘤患者(90% vs 65%,p = 0.001;85% vs 49%,p = 0.005)。与其他高危 HPV 型相比,HPV-16 相关 OPSCC 更易发生颈部转移(p = 0.005),且无病生存率较差,但无统计学意义。

结论

HPV-16 感染是安大略省西南部 OPSCC 的主要病因。其他高危亚型导致一小部分 OPSCC,这些患者较少发生颈部转移,且预后可能不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/944b/3650940/f817e30d681a/1916-0216-42-9-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/944b/3650940/1290b5205e30/1916-0216-42-9-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/944b/3650940/f817e30d681a/1916-0216-42-9-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/944b/3650940/1290b5205e30/1916-0216-42-9-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/944b/3650940/f817e30d681a/1916-0216-42-9-2.jpg

相似文献

1
Does HPV type affect outcome in oropharyngeal cancer?HPV 型别是否影响口咽癌的预后?
J Otolaryngol Head Neck Surg. 2013 Feb 1;42(1):9. doi: 10.1186/1916-0216-42-9.
2
A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.一项关于人乳头瘤病毒(HPV)与口腔及口咽鳞状细胞癌的临床病理参数及预后之间关联的系统性研究。
Cancer Med. 2017 May;6(5):910-917. doi: 10.1002/cam4.1045. Epub 2017 Apr 4.
3
Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.应用液滴数字聚合酶链反应检测口咽鳞癌中人乳头瘤病毒 16 型。
Cancer. 2016 May 15;122(10):1544-51. doi: 10.1002/cncr.29976. Epub 2016 Mar 17.
4
Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.由人乳头瘤病毒和表皮生长因子受体状态所确定的分子亚分类与口咽鳞状细胞癌的预后相关。
Hum Pathol. 2016 Apr;50:51-61. doi: 10.1016/j.humpath.2015.11.001. Epub 2015 Nov 17.
5
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.生物标志物 p16 在口咽鳞状细胞癌中的预后意义。
Clin Oncol (R Coll Radiol). 2013 Nov;25(11):630-8. doi: 10.1016/j.clon.2013.07.003. Epub 2013 Jul 31.
6
Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma.人乳头瘤病毒相关口咽癌中上皮-间充质转化的诱导和 podoplanin 表达的丧失与淋巴结转移的进展相关。
Histopathology. 2015 May;66(6):771-80. doi: 10.1111/his.12496. Epub 2014 Nov 10.
7
CD8 T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer.CD8 T细胞对人乳头瘤病毒16 E7的反应能够预测口咽癌的生存结果。
Eur J Cancer. 2016 Nov;67:141-151. doi: 10.1016/j.ejca.2016.08.012. Epub 2016 Sep 24.
8
High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.高危E6基因表达可预测人乳头瘤病毒阳性口咽鳞状细胞癌患者的远处转移和不良生存情况。
Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1132-41. doi: 10.1016/j.ijrobp.2016.03.001. Epub 2016 Mar 10.
9
HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.人乳头瘤病毒16型(HPV-16)感染可预测口咽鳞状细胞癌的治疗结果。
Otolaryngol Head Neck Surg. 2009 Feb;140(2):228-34. doi: 10.1016/j.otohns.2008.11.025.
10
[Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].[人乳头瘤病毒(HPV)阳性口咽鳞状细胞癌的临床病理特征]
Zhonghua Bing Li Xue Za Zhi. 2019 Feb 8;48(2):127-131. doi: 10.3760/cma.j.issn.0529-5807.2019.02.010.

引用本文的文献

1
lncRNA Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients.长链非编码RNA是HPV感染的标志物及头颈部鳞状细胞癌患者的预后因素。
Biomedicines. 2025 Mar 26;13(4):798. doi: 10.3390/biomedicines13040798.
2
Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes.人乳头瘤病毒基因型和系统发育分支与口咽癌结局的关系。
Oncologist. 2024 Nov 4;29(11):966-977. doi: 10.1093/oncolo/oyae202.
3
A Review and Comparative Analysis of Transoral Surgical Treatment versus Conservative Management in Early-Stage Oropharyngeal Cancer.

本文引用的文献

1
HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.HPV 基因型及其在头颈部鳞状细胞癌中的预后意义。
J Clin Virol. 2012 Feb;53(2):116-20. doi: 10.1016/j.jcv.2011.11.005. Epub 2011 Dec 15.
2
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.HPV 疫苗预防肛门 HPV 感染和肛门上皮内瘤变。
N Engl J Med. 2011 Oct 27;365(17):1576-85. doi: 10.1056/NEJMoa1010971.
3
Human papillomavirus and rising oropharyngeal cancer incidence in the United States.人乳头瘤病毒与美国口咽癌发病率的上升
早期口咽癌经口手术治疗与保守治疗的综述及对比分析
J Pers Med. 2024 Mar 4;14(3):283. doi: 10.3390/jpm14030283.
4
HPV16 Intratypic Variants in Head and Neck Cancers: A North American Perspective.HPV16 型头颈部肿瘤的同型内变异:北美的观点。
Viruses. 2023 Dec 12;15(12):2411. doi: 10.3390/v15122411.
5
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.根据人乳头瘤病毒亚型分层的口咽鳞状细胞癌的临床结局:系统评价和荟萃分析。
Oral Oncol. 2024 Jan;148:106644. doi: 10.1016/j.oraloncology.2023.106644. Epub 2023 Nov 24.
6
Impact of HR-HPV infection on oncological outcomes in early cervical cancer.高危型人乳头瘤病毒(HR-HPV)感染对早期宫颈癌肿瘤学结局的影响
Front Oncol. 2023 Aug 28;13:1264114. doi: 10.3389/fonc.2023.1264114. eCollection 2023.
7
Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.生物信息学分析鉴定出 HPV 相关的头颈部鳞状细胞癌肿瘤微环境重塑的预后生物标志物。
Front Cell Infect Microbiol. 2022 Nov 8;12:1007950. doi: 10.3389/fcimb.2022.1007950. eCollection 2022.
8
The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma.人乳头瘤病毒在决定头颈部鳞状细胞癌的治疗、生存及预后方面的作用
Cancers (Basel). 2022 Sep 3;14(17):4321. doi: 10.3390/cancers14174321.
9
Comprehensive Viral Genotyping Reveals Prognostic Viral Phylogenetic Groups in HPV16-Associated Squamous Cell Carcinoma of the Oropharynx.全面的病毒基因分型揭示了 HPV16 相关口咽鳞状细胞癌中具有预后意义的病毒进化群。
Mol Cancer Res. 2022 Oct 4;20(10):1489-1501. doi: 10.1158/1541-7786.MCR-21-0443.
10
HPV E1 qPCR, a Low-Cost Alternative Assay to Roche Diagnostic Linear Array is Effective in Identifying Women at Risk for Developing Cervical Cancer.人乳头瘤病毒E1定量聚合酶链反应,作为罗氏诊断线性阵列的一种低成本替代检测方法,在识别有患宫颈癌风险的女性方面是有效的。
Int J Womens Health. 2022 Feb 19;14:257-266. doi: 10.2147/IJWH.S347546. eCollection 2022.
J Clin Oncol. 2011 Nov 10;29(32):4294-301. doi: 10.1200/JCO.2011.36.4596. Epub 2011 Oct 3.
4
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.头颈部鳞状细胞癌外显子组测序揭示 NOTCH1 中的失活突变。
Science. 2011 Aug 26;333(6046):1154-7. doi: 10.1126/science.1206923. Epub 2011 Jul 28.
5
The mutational landscape of head and neck squamous cell carcinoma.头颈部鳞状细胞癌的突变全景。
Science. 2011 Aug 26;333(6046):1157-60. doi: 10.1126/science.1208130. Epub 2011 Jul 28.
6
Human papillomavirus and survival of patients with oropharyngeal cancer.人乳头瘤病毒与口咽癌患者的生存。
N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.
7
HPV-associated head and neck cancer: a virus-related cancer epidemic.人乳头瘤病毒相关性头颈部癌症:一种与病毒相关的癌症流行。
Lancet Oncol. 2010 Aug;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6. Epub 2010 May 5.
8
Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada.加拿大确诊肛门生殖器疣发病率和患病率的二十年趋势。
Sex Transm Dis. 2009 Jun;36(6):380-6. doi: 10.1097/OLQ.0b013e318198de8c.
9
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.24至45岁女性四价人乳头瘤病毒(6、11、16、18型)重组疫苗的安全性、免疫原性及有效性:一项随机双盲试验
Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1.
10
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?瑞典斯德哥尔摩人乳头瘤病毒(HPV)阳性扁桃体癌的发病率:一种病毒诱导的癌症流行?
Int J Cancer. 2009 Jul 15;125(2):362-6. doi: 10.1002/ijc.24339.